Simple jQuery Dropdowns

Browsing by Author Wiroj Mankatitham

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 7 to 10 of 10 < previous 
Issue DateTitleAuthor(s)
1-May-2011Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective studyWeerawat Manosuthi; Aroon Lueangniyomkul; Wiroj Mankatitham; Sukanya Chimsuntorn; Preecha Tantanathip; Supeda Thongyen; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
15-Jun-2009A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in hiv-infected patients receiving rifampicin: The n<inf>2</inf>r studyWeerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Aroon Lueangniyomkul; Wiroj Mankatitham; Wisit Prasithsirskul; Sunantha Burapatarawong; Supeda Thongyen; Sirirat Likanonsakul; Unchana Thawornwa; Vilaiwan Prommool; Kiat Ruxrungtham; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Chulalongkorn University
11-Oct-2010Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimensWeerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Wisit Prasithsirikul; Preecha Tantanathip; Busakorn Suntisuklappon; Anongnuch Narkksoksung; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Aug-2012Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: Results From the TIME studyWeerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Supeda Thongyen; Sirirat Likanonsakul; Pawita Suwanvattana; Unchana Thawornwan; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University